Additionally, TIAR is first identified as a cytotoxicity T cell granule component and whether increased TIAR in HCC tissues affects CD8 + T cell function, and then affects the progression of HCC is unclear. This evidence concerns the gene CD8A and hepatocellular carcinoma.